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1. Introduction 
It is now widely accepted that cancer development is a multistage process that results from 
an accumulation of mutations (Lengauer et al., 1998). Since spontaneous mutation rates in 
human cells are considerably lower then the large number of mutations observed in cancer 
cells, cancer cells must be a manifestation of the mutator phenotype. The mutator 
phenotype, also referred to as genomic instability, designates the increased mutation rate 
that occurs in neoplastic cells (Loeb, 1991). The induction of the genomic instability 
phenotype is emerging to be a crucial early event in carcinogenesis that enables an initiated 
cell to evolve into a cancer cell by achieving a greater proliferative capacity and genetic 
plasticity, which can overcome host immunological resistance, localized toxic environments 
and a suboptimal supply of micronutrients (Loeb, 1991; Cahill et al., 1999; Fenech 2002). 
Two distinct forms of genomic instability have been identified, microsatellite instability 
(MIN) and chromosomal instability (CIN). They probably encompass most characterized 
malignances (Lengauer et al., 1998; Breivik & Gaudernack, 1999). Genomic instability is 
present in all stages of cancer, from precancerous lesions to advanced cancers (Negrini et al., 
2010; Markovic et al., 2008) 
Measurements of instability have been performed by a variety of techniques, including flow 
cytometry, comparative genomic hybridization (CGH), allelotyping, and analysis of gene 
amplification rates (Vogelstein et al., 1989; Kallioniemi et al., 1994; Jass et al., 1994). These 
approaches, although informative, are generally cumbersome and somewhat impractical for 
widespread clinical use. Unlike these techniques, DNA fingerprinting methods, RAPD 
(Random Amplified Polymorphic DNA) and AP-PCR (Arbitrarily Primed Polymerase 
Chain Reaction) are rapid and simple procedures that examine the whole genome and 
detect the propensity of a tumor to undergo genomic rearrangements (Peinado et al., 1992; 
Perucho et al., 1996).  
AP-PCR is a PCR-based DNA fingerprinting method that utilizes arbitrarily chosen primers 
to co-amplify multiple and independent sequences under low stringency conditions during 
the first cycles. It was first described by Welsh and McClelland (1990), who designed it to 
amplify multiple DNA fragments from anonymous regions of the genome. Initial cycles of 
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the reaction are performed under low stringency conditions which are achieved with low 
temperatures during the annealing step of PCR and/or high magnesium concentration in 
the reaction. Under these conditions the arbitrary primer anneals to the best matches in the 
template. The priming events during the initial low stringency cycles are arbitrary since they 
depend on the nucleotide sequence of the PCR primer, which is arbitrarily chosen. 
Competition between these annealing events results in reproducible and quantitative 
amplification of many discrete bands. Further amplification of these sequences (discrete 
bands) under high stringency conditions produces a complex fingerprint which can be 
visualized by gel electrophoresis. The obtained band pattern is characteristic and 
representative of the genome used as template.  
The large number of bands amplified with a single arbitrary primer generates a complex 
fingerprint that can be used to detect differences in the arbitrary amplified DNA sequences 
from two different but closely related genomes, like DNA from normal and cancer cells. 
Such differences correspond to somatic genetic alterations. In addition, AP-PCR method 
permits direct cloning and identification of altered variant bands i.e. altered DNA 
sequences. Therefore, this unbiased methodology allows for molecular karyotyping of 
somatically acquired genomic abnormalities, comparing related genomes, whereby one is a 
derivative of the other emerging via undefined and abnormal genomic events. Indeed, AP-
PCR has been successfully used as a molecular alternative for cancer cytogenetics since it 
has proved to be capable of detecting chromosomal gains and losses as well as point 
mutations associated with carcinogenesis (Perucho et al., 1996; Chariyalertsak et al., 2005). 
This is based on the following favorable properties of the method: (i) the amplified bands 
usually originate from single copy sequences rather then from repetitive elements; (ii) there 
is no apparent bias for the chromosomal origins of the amplified bands, and therefore, 
fingerprints representative of the full chromosomal complement can be obtained by using a 
few arbitrary primers; (iii) the amplification is semi-quantitative, that is, the intensities of the 
amplified bands are almost proportional to the concentration of the corresponding template 
sequences.  
Taking into account the potential and advantages of AP-PCR method, it seems as a 
reasonable approach to use this method to detect and quantify the level of genomic 
instability in various cancer samples. Therefore, we applied AP-PCR to measure genomic 
instability in samples of patients with Non Small Cell Lung Carcinoma (NSCLC) of various 
stages and grades, samples of patients with Malignant Gliomas of various grades 
(Anaplastic Astrocytomas and Glioblastomas) and samples of patients with Head and Neck 
Squamous Cell Carcinoma (HNSCC) and their premalignant lesions leukoplakias. 
Moreover, we aimed to identify some of these genomic alterations associated with the 
process of carcinogenesis in these types of tumors. 
Here we describe the procedure for analyzing the level of genomic instability and 
identifying specific genetic alterations that occur during the tumorigenic process by 
Arbitrarily Primed PCR. This procedure involves the following steps: (i) comparative AP-
PCR analysis of matching normal and tumor tissue and determination of the frequency of 
DNA alterations, a measurement of genomic instability; (ii) correlation between the level of 
genomic instability and histological grade and stage of each tumor; (iii) isolation and 
identification of altered amplified bands. Obtained results are presented and discussed in 
terms of the evolution of these types of tumors. 
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2. Materials and methods 
2.1 Tissue samples and DNA extraction 
Paired tumor and normal tissue samples (adjacent normal lung tissue and blood for 
malignant gliomas, HNSCC and leukoplakias) were analyzed. Specifically, 30 malignant 
glioma patients who underwent surgical resection at Clinic for Neurosurgery, Clinical 
Center of Serbia, 30 NSCLC patients who underwent surgery at the Institute for Lung 
Diseases and Tuberculosis, Clinical Centre of Serbia, 32 leukoplakia patients and 30 HNSCC 
patients who underwent surgery at the Clinic of Maxillofacial Surgery, School of Dentistry, 
University of Belgrade. Freshly excised tissue samples were partitioned for histopathology 
and DNA analyses. The specimens for DNA analyses were frozen in liquid nitrogen until 
DNA extraction. The samples were collected and used after obtaining informed consents 
and approval from the Ethics Committee, in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki. 
DNA was extracted using the phenol/chloroform/isoamyl alcohol method (Sambrook et al., 
1989). The quality of the DNA was verified by electrophoresis on 0.8% agarose gel. The 
DNA concentration was assessed spectrophotometrically. 
2.2 AP-PCR DNA fingerprinting 
Genomic instability was determined by comparing the AP-PCR profiles of paired tumor and 
normal DNA samples of the same patient. Altogether, twenty primers were tested for the 
ability to generate informative fingerprints that distinguish tumor from normal tissue. 
Optimization of AP-PCR reactions was done for each primer according to Cobb (1997) and 
included the search for conditions that would yield profiles of moderate complexity in order 
to simplify the analysis (McClelland & Welsh, 1994). Normally, optimization of AP-PCR 
DNA fingerprinting would require each variable to be tested independently. An experiment 
investigating the effects and interactions of four critical reaction components (dNTPs, 
MgCl2, primer and DNA), each at three concentrations, would require 81 (i.e., 34) separate 
reactions. However, using modified Taguchi method (Taguchi & Wu, 1980, as cited in Cobb, 
1997) only nine reactions are required to perform the same optimization. Here an estimate of 
the effect of individual components is achieved by looking at the effects that component 
interactions have on the fingerprint. These interactions are determined by arranging those 
components that are likely to affect the reactions into an orthogonal array. The product yield 
for each reaction is used to estimate the effects of individual components on amplification. 
We varied the PCR components in the following final concentrations: dNTPs (0.2 mM, 0.4 
mM, 0.6 mM), MgCl2 (1.5 mM, 2.5 mM, 3.5 mM), primer (1.5 μM, 3.0 μM, 5.0 μM) and DNA 
(50 ng, 100 ng, 150 ng). DNA concentration did not affect AP-PCR fingerprints and it was 
used to validate the method. Namely, after optimal reaction conditions were established, 
each experiment included the analysis of two template concentrations (25 ng and 50 ng in a 
final volume of 25 µL) for each individual in order to exclude artifacts arising from 
impurities in the DNA preparations. 
Twelve out of twenty primers produced informative profiles differentiating normal from 
tumor tissue. Primer sequences, AP-PCR conditions and reaction mixtures are given in 
Table 1. 
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Primer Primer sequence 
AP-PCR low-stringency 
conditions 
AP-PCR high-stringency 
conditions 
CCNA1 
5’-AAG AGG ACC AGG 
AGA ATA TCA-3’ 
95oC 30″ 45oC 2′ 72oC 1′ 95oC 30″ 60oC 1′ 72oC 1′ 
LRP-A 
5’-GCT TCC GAG GTC 
TCA AAG C-3’ 
95oC 30″ 40oC 2′ 72oC 1′ 95oC 30″ 58oC 1′ 72oC 1′ 
MDR-A 
5’-GTT CAA ACT TCT 
GCT CCT GA-3’ 
95oC 30″ 40oC 2′ 72oC 1′ 95oC 30″ 58oC 1′ 72oC 1′ 
E8S p53 
5’-TAA ATG GGA CAG 
GTA GGA CC-3’ 
95oC 30″ 40oC 2′ 72oC 1′ 95oC 30″ 58oC 1′ 72oC 1′ 
GAPDH-S 
5’– CGG AGT CAA CGG 
ATT TGG TCG TAT– 3’ 
95ºC 30’’; 50ºC 2’; 72ºC 1’ 95ºC 30’’; 70ºC 1’; 72ºC 1’ 
GAPDH-A 
5’–AGC CTT CTC CAT 
GGTGGT GAA GAC–3’ 
950C 30”; 500C 2’; 720C 1’ 950C 30”; 720C 1’; 720C 1’ 
E5A p53 
5’–CAG CCC TGT CGT 
CTC TCC AG–3’ 
950C 30”; 400C 2’; 720C 1’ 950C 30”; 550C 1’; 720C 1’ 
p53 A 
5’–TTG GGC AGT GCT 
CGC TTA GT–3’ 
950C 30”; 400C 2’; 720C 1’ 950C 30”; 600C 1’; 720C 1’ 
H61-5’ 
5’-AGG TGG TCA TTG 
ATG GGG AG-3’ 
940C 1’; 450C 2”, 720C 2’ 940C 1’; 620C 1’; 720C 2’ 
w
w
w
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The reactions consisted of an initial denaturation step (95ºC for 5 min), 4 cycles at low-
stringency conditions (specific for each primer), 35 cycles at high-stringency conditions 
(specific for each primer), and a final extension (72ºC for 7 min) in a GeneAmp® PCR System 
9700 (Applied Biosystems, Foster City, California, USA). 
The AP-PCR products were separated on 6 – 8% non-denaturing polyacrylamide (PAA) gels 
and visualized by silver staining. Silver- staining procedure creates permanent record of the 
electrophoresis results and includes several steps: fixing, silver impregnation, development 
and stopping the reaction. In the fixing step, the gel is treated with 1% nitric acid solution to 
render the macromolecules in the gel insoluble and prevent diffusion during the subsequent 
staining steps. In the silver impregnation step, soluble silver ion (Ag+) derived from the 
silver nitrate, 12mM AgNO3 solution, binds to nucleic acid bases fixed in gel. Generally, 
DNA bases promotes the reduction of silver ion to metallic silver (Ag0), which is insoluble 
and visible, allowing nucleic acid-containing bands to be seen. In order to prevent reduction 
of silver ion to metallic silver before the end of silver impregnation, this step is often 
performed in mildly acidic acid conditions. During the development step, formaldehyde 
reduces silver ions to metallic silver in process that only proceed at high pH, approximately 
12. For that reason, sodium carbonate is included as one of the main component that render 
development solution alkaline. Stopping reaction step imply prevention of any further silver 
ion reduction by soaking the gels in the 10 % acetic acid solution. Finally, it should be 
emphasized that water washes are also included between some of the above mentioned 
steps in the silver staining procedure (detailed procedure is given in Table 2). 
 
Step Solution Time 
 
Fixation Pretreatment 
 
Fixation 
 
Water Washing 
 
Silver Impregnation 
 
Water Washing 
 
Developing - Reduction 
 
 
Stopping Reduction 
 
10%  Ethanol 
 
1% Nitric Acid Solution 
 
Destiled H2O 
 
12 mM Silver Nitrate Solution 
 
Destiled H2O 
 
0.28 M Sodium Carbonat  with 
0.019 % Formaldehyde 
 
10 % Acetic Acid 
 
10 minutes 
 
3 minutes 
 
2 x 1 minute 
 
30 minutes 
 
3 x 1 minutes 
 
Until  desired images 
appear 
 
5 – 10 minutes 
Table 2. In-house procedure for silver- staining of PAA gels. 
Gel images were acquired with the Multi-Analyst/PC Software Image Analysis System (Bio 
Rad Gel Doc 1000). Digitized images were loaded into the specialized public software Image 
J (National Institute of Health, USA, www.rsb.info.nih.gov/ij) and analyzed by the image 
enhancement function ‘adapthisteq’. This function performs contrast-limited adaptive 
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histogram equalization on small regions of the image, called tiles. Contrast of each tile is 
enhanced so that the histogram of the output region approximately matches a specified 
histogram. After equalization, adapthisteq combines neighboring tiles using bilinear 
interpolation to eliminate artificially induced boundaries. 
2.2.1 Reproducibility 
The problem of reproducibility of AP-PCR has been a matter of concern for quite some time 
(Meunier and Grimont, 1993; McClelland and Welsh, 1994). In our study, reproducibility 
was verified by at least three independent reactions and a reaction with a two-fold higher 
template concentration. Occasional irreproducibility was found to be due to template 
quality, where additional round of purification solved the problem. Template carry-over 
was routinely monitored by systematic incorporation of "no-template reaction" in each set of 
experiments. Day to day variation was found only in respect of band intensities. This 
variability was in the range of less than 10% (± 5%) as estimated by integration of 
densitometric scans. Interlab variation was not assessed but we presume that it does not 
affect the interpretation of data from this report. 
2.3 Isolation, cloning and DNA sequencing of variant bands obtained by AP-PCR 
Selected variant DNA bands, bands with altered mobility, were further characterized. The 
PCR amplicons resolved on the silver stained gels were gently removed with a hypodermic 
22-gauge needle pre-wetted with the PCR master mix solution. The needle was dipped in 
the PCR master mix for 2 min and then discarded. The PCR products were reamplified with 
the same primers used for AP-PCR reactions at high-stringency conditions specific for each 
particular primer. The reamplified material was administrated on 1.5% agarose gels, 
purified using DNA Extraction Kit (Fermentas Life Sciences, Lithuania) and cloned with 
GeneJetTM PCR Cloning Kit (Fermentas Life Sciences, Lithuania) according to 
manufacturers’ instructions. Plasmids were purified using GeneJetTM Plasmid Miniprep Kit 
(Fermentas Life Sciences, Lithuania). 
Cloning process consisted of setting up the blunting and ligation reactions. Blunting 
reaction allows the conversion of PCR products generated with non-proofreading Taq DNA 
polymerase to DNA fragments with blunt ends using thermostable DNA Blunting Enzyme 
provided with the kit. The reaction consists of 10 μL of 2x Reaction Buffer, 2 μL of non-
purified PCR product, 5 μL of nuclease free water and 1 μL of DNA Blunting Enzyme in 18 
μL reaction mixture. The resulting blunt-ended DNA can be ligated efficiently into a vector, 
pJET1.2/blunt, using the included DNA Ligation Kit Solutions: 1 μL of pJET1.2/blunt 
Cloning Vector (50ng/ μl) and 1 μL of T4 DNA Ligase (5u/μl). The vector contains a lethal 
restriction enzyme gene that is disrupted by ligation of a DNA insert into the cloning site. 
As a result, only bacterial cells with recombinant plasmids are able to form colonies. 
Recircularized pJET1.2/blunt vector molecules lacking an insert express a lethal restriction 
enzyme which kills the host E.coli cell after transformation. This positive selection drastically 
accelerates the process of colony screening and eliminates additional costs required for 
blue/white selection. The reactions can be used directly for bacterial transformation and in 
vitro packaging procedures without further purification. All common laboratory E.coli 
strains can be directly transformed with the ligation product.  
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Before the transformation procedure, the preparation of competent bacteria of E. coli 
GM2163 strain was performed using TransformAidTM Bacterial Transformation Kit 
(Fermentas Life Sciences, Lithuania) according to the manufacturer instruction. 
The next step was to recover plasmid DNA from recombinant E.coli cultures using 
GeneJETTM Plasmid Miniprep Kit (Fermentas Life Sciences, Lithuania). A single colony was 
picked from a freshly streaked selective plate for inoculation of 5 mL of LB liquid medium 
(Fermentas Life Sciences, Lithuania) supplemented with the ampicillin. A bacterial culture is 
harvested and lysed. The lysate is then cleared by centrifugation and applied on the silica 
column to selectively bind DNA molecules at a high salt concentration. The adsorbed DNA 
is washed to remove contaminants, and the pure plasmid DNA is eluted in a small volume 
of elution buffer or water. The purified DNA is ready for immediate use in all molecular 
biology procedures such as automated sequencing. Before sequencing, the ligation of DNA 
fragment into the plasmid was verified using restriction enzymes HindIII and EcoRI (Sigma-
Aldrich Chemie GmbH, Germany). The fragments obtained after restriction were analyzed 
on 1% agarose gels. The sequencing was performed only after the presence of the DNA 
fragment in plasmid was confirmed by comparing the molecular weight of recombinant 
plasmid with DNA ladder. 
Sequences were determined on ABI Prism 3130 Genetic Analyzer automated sequencer 
(Applied Biosystems, Foster City, CA, USA) using BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems, Foster City, CA, USA). Sequencing was performed in 
both directions on several clones for each selected DNA band. The obtained sequences were 
analyzed using BLAST software in the NCBI GenBank and EBI (Sanger Institute) database. 
The sequencing procedure itself involved: 1) two independent cycle sequencing PCRs, each 
with one primer only (5’ and 3’), for the sequencing in both directions; 2) precipitation of the 
amplicons; 3) their denaturation and 4) automatic electrophoresis. Cycle sequencing PCRs 
were performed on the GeneAmp® PCR System 9700 (Applied Biosystems, Foster City, CA, 
USA) using BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, 
CA, USA) with the final concentration of 100-300 ng of the plasmid DNA and 4pmol of the 
primer under the following conditions: initial denaturation at 96°C for 1 min, 25 cycles at 
96°C for 10 s, 50°C for 5 s, 60°C for 4 min and at 4°C indefinitely. The obtained PCR 
products were precipitated and EDTA (25 mM final) and EtOH (70-75% final) added.The 
mixture was incubated for 15 min at RT and then centrifuged 30-45 min at 6000 rpm and 
+4°C. The supernatant was removed, a new quantity of 70% EtOH added, followed by 
centrifugation for 25 min at 5000 rpm and +4°C. Supernatant was removed again and the 
obtained pellet dried at 90°C. Then, 15 μl of Hi-DI™ Formamide (Applied Biosystems, 
Foster City, CA, USA) was added for the denaturation at 95°C. 10 μl of the amplicons 
dissolved in formamide were subjected to the automatic electrophoresis and sequence 
reading on ABI Prism 3130 Genetic Analyzer automated sequencer (Applied Biosystems, 
Foster City, CA, USA). The obtained sequences were analyzed using BLAST software in the 
NCBI GenBank and EBI (Sanger Institute) database. 
3. Results and discussion 
Genomic instability was determined by comparing the AP-PCR profiles of DNA isolated 
from paired normal and tumor tissues of patients with non small cell lung cancer (NSCLC), 
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malignant glioma, head and neck squamous cell carcinoma (HNSCC) and leukoplakia (L). 
Twelve out of twenty tested primers produced informative amplification profiles 
differentiating normal from tumor tissue or normal from leukoplakia (Table 1). Specifically, 
five primers produced informative sequence alterations that distinguish NSCLC from 
normal tissue, a set of four primers produced informative fingerprints differentiating 
malignant gliomas from normal tissue and another set of four primers produced 
informative sequence alterations that distinguish HNSCC and leukoplakias from their 
normal counterparts. The AP-PCR products were separated on 6-8% nondenaturing 
polyacrylamide (PAA) gels and visualized by silver staining. Typical fingerprints are 
shown in Figure 1. 
 
Fig. 1. AP-PCR fingerprint profiles of tumor (T) and normal (N) tissues from patients with 
NSCLC obtained with GAPDH AS primer. Reactions were performed in duplicate with 25 
ng and 50 ng of DNA. Numbers 1–5 represent the patients; M–the DNA ladder; NTC–no 
template control. Arrows and arrowheads indicate examples of quantitative and qualitative 
changes, respectively. 
www.intechopen.com
Analysis of Genomic Instability  
and Tumor-Specific Genetic Alterations by Arbitrarily Primed PCR 
 
477 
This type of analysis differentiates individuals and, thus, displays the cardinal feature of 
the DNA profile analysis. Additionally, some bands are characteristic for the human 
genome, being common to all analyzed patients. Importantly, some electrophoretic bands 
were present in DNA profiles of tumor but not in normal tissue, and vice versa, indicating 
the mutational like events. The unbiased nature of AP-PCR profiling allows for the 
screening of anonymous regions of a genome without any prior knowledge of its 
structure (Welsh and McClelland, 1990; Williams et al., 1990) and provides information 
about two distinct types of DNA alterations: qualitative and quantitative. Qualitative 
differences, which represent microsatellite instability (MIN), are detected as mobility 
shifts in the banding pattern, i.e., the presence or absence of specific bands in tumor and 
control samples. Quantitative differences appear as altered band intensities and represent 
amplifications or deletions of existing chromosomal material as manifestations of 
chromosomal instability (CIN). Observed changes should be cautiously regarded as semi-
quantitative and semi-qualitative due to the competitive nature of AP-PCR where 
sequence context may play unpredictable role. This situation may present a serious 
problem for simple to moderate patterns but not for complex patterns. Unfortunately, the 
former are preferred due to simplicity of interpretation. Since the profile is the result of a 
competition between many PCR products, the problem may appear with very simple 
profiles in analysis of similar but non-identical genomes. For this reason, it had been 
suggested to use profile pattern with more than 10 prominent PCR products of moderate 
complexity (McClelland and Welsh, 1994). We followed this reasoning and the necessary 
precautions for reproducibility and reliability of DNA profiling analysis in comparing 
DNA fingerprints of paired normal – tumor samples. We identified significant genomic 
instability in most cases as qualitative and quantitative electrophoretic changes. The 
qualitative alterations represented as a loss or a gain of a band are the result of mutations 
at the primer-template interaction sites leading to a mobility shift of a band. Quantitative 
changes were observed as bands of either decreased or increased intensity. Allelic losses, 
which may occur as a result of their linkage to suppressor genes, produce bands with 
decreased intensity. Gene amplification or chromosomal aneuploidy appears as bands 
with increased intensity.  
For each type of DNA change, as well as for the total number of changes, the frequency of 
DNA alterations, a measurement of genomic instability, was calculated as the number of 
altered bands in the AP-PCR profile of tumor tissue divided by the total number of 
amplicons in the fingerprint of normal tissue from each patient. AP-PCR fingerprints were 
analyzed and qualitative and quantitative changes determined using image enhancement 
function ‘adapthisteq’ of the specialized public software Image J (Figure 2). 
DNA alterations were detected in all analyzed samples with the frequency varying among 
different types of tumors (Table 3). The largest variation of the frequency of total DNA 
alterations was in NSCLC patients ranging from 8% to even 68%. The contribution of 
qualitative changes to overall genomic instability was significantly greater than the 
contribution of quantitative changes. This large range of instability raised the question of its 
distribution among samples of NSCLC patients. In other words we were interested to see if 
there was association between the level of genomic instability and any clinicopathological 
parameter. 
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Fig. 2. AP-PCR fingerprinting analysis of genomic instability in glioma samples. AP-PCR 
profiles of tumor (T) and blood (N) tissues from the same patient obtained using MDRa 
primer, separated on 6% non-denaturing polyacrylamide (PAA) gel and corresponding 
contrast-limited adaptive histograms obtained using image enhancement function 
‘adapthisteq’ of the specialized public software Image J (A). Arrows and arrowheads 
indicate examples of qualitative and quantitative electrophoretic changes respectively, 
clearly seen on the overlap of tumor and blood histograms (B). 
The most noteworthy finding of this study was the association between the level of genomic 
instability and histological grades of NSCLC. Namely, we found the significant decrease of 
the total number of DNA alterations with increasing histological grade of the NSCLC. The 
same pattern was found for quantitative changes alone – the frequency of alterations 
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decreased with the increase of the histological grade (Figure 3). These results support the 
idea that mutational alterations conferring genomic instability and the mutator phenotype 
occur early during tumor formation. The mutator phenotype hypothesis proposes that such 
phenotypes result from mutations in genes that maintain genomic stability in normal cells. 
Instability promotes mutations in other genes, oncogenes and tumor suppressor genes, 
providing the tumor cell with a selective growth advantage. These findings strongly support 
the increasingly popular explanation of neoplastic transformation in terms of Darwinian 
evolutionary mechanisms (Breivik, 2001; Breivik & Gaudernack, 1999; Cahill et al., 1999). 
Evolution through natural selection depends on two essential elements, the availability of 
 
type of DNA 
alteration 
frequency of DNA alterations 
NSCLC glioma leukoplakia HNSCC 
qualitative 0.07 – 0.53 0.06 – 0.27 0.18 – 0.41 0.05 – 0.21 
quantitative 0.01 – 0.16 0.05 – 0.27 0.07 – 0.16 0.07 – 0.21 
TOTAL 0.08 – 0.68 0.14 – 0.49 0.30 – 0.48 0.12 – 0.31 
Table 3. Measurement of genomic instability in various types of tumors. 
 
Fig. 3. The relationship between the total frequency of DNA alterations and the histological 
grades of the lung tumors. All values are presented as means ± SEM. # p < 0.05 when grade 
1 was compared to grade 2; *** p < 0.005 when grade 1 was compared to grade 3; & p < 0.05 
when grade 2 was compared to grade 3. 
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genetic variation and selection pressure (Dawkins, 1989.). In general evolutionary terms, it 
could be said that genomic instability accelerates the somatic evolutionary process by 
promoting genetic variation in an organism. Extensive genomic instability is thus expected 
in early phases of cancer progression (histological grade 1 in this study). At the same time, 
an increased mutation rate is expected to cause mutations that are deleterious or lethal at 
higher frequencies rather than mutations that have favorable effects on cellular proliferation. 
Consequently, elevated mutation rates must generally be regarded as disadvantageous to 
cellular growth (Tomlinson et al.,1996). Theoretical arguments suggest that the 
accumulation of large numbers of mutations can exceed the error threshold for cell 
replication and viability (Eigen, 1993). Only cells carrying reasonable number of mutations 
with favorable effects on cell growth would survive. Therefore, it seems probable that the 
expression of the mutator phenotype could be decreased and lost in the late phases of tumor 
progression. As a result, tumors may no longer exhibit a mutator phenotype but will 
nevertheless reveal its history, i.e. random mutations, throughout their genome (Loeb, 2001). 
In other words, the result showing the lower degree of genomic instability in advanced 
NSCLCs (grades 2 and 3) is not unexpected in the light of these arguments and could be 
considered as a marker of poor prognosis. 
Following the study of genomic instability in NSCLC tissue samples, we made an attempt to 
identify some of detected DNA changes in order to identify genes that alter during NSCLC 
promotion and progression (Bankovic et al., 2010). Selected DNA bands with altered 
mobility were further characterized. Twenty one unique bands present only in tumor but 
not in normal tissue were retrieved from the gels and cloned. Variant bands that appeared 
in more than one sample (new bands with the same mobility), were chosen in order to 
identify DNA alterations common to as many NSCLC patients as possible. Bands 
(amplicons) with the same electrophoretic mobility were isolated and characterized from at 
least two patients in order to confirm that they represent the same DNA sequence. Three 
clones of each band were sequenced. Obtained sequences were submitted to homology or 
identity search in NCBI GenBank and EBI (Sanger Institute) databases. Following genes 
were identified: tetraspanin 14 (TSPAN14), cadherin 12 (CDH12), retinol dehydrogenase 10 
(RDH10), cytochrome P450, family 4, subfamily Z, polypeptide 1 (CYP4Z1), killer cell 
immunoglobulin-like receptor (KIR), E2F transcription factor 4 (E2F4), phosphatase and 
actin regulator 3 (PHACTR3), PHD finger protein 20 (PHF20), PRAME (preferentially 
expressed antigen in melanoma) family member and solute carrier family 2 (facilitated 
glucose transporter), member 13 (SLC2A13). Moreover, we were able to identify types of 
mutations in revealed genes according to sequence data and BLAST search results and to 
examine their presence in relation to NSCLC subtype, histological grade and stage of the 
tumor, lymph node invasion and patients’ survival. Examining their relation to the patients’ 
clinicopathological parameters and survival we concluded that TSPAN14, SLC2A13 and 
PHF20 could have a role in NSCLC promotion, CYP4Z1, KIR and RDH10 would possibly 
play a role in NSCLC progression, while E2F4, PHACTR3, CDH12 and PRAME family 
member probably play important role in NSCLC geneses. Patients with altered E2F4 and 
PHACTR3 lived significantly shorter. 
Unlike NSCLC samples, all leukoplakias demonstrated extensive instability in a relatively 
small range (Table 3). The frequency of total DNA alterations ranged from 0.30 to 0.48 and  
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clearly distinguished two groups of leukoplakias: a group of six leukoplakias had a 
frequency of DNA alterations of 0.3–0.34 and was  denoted as leukoplakias with a moderate 
degree of instability while the other group of 26 leukoplakias had a frequency of DNA 
alterations of > 0.4 and was denoted as leukoplakias with a high degree of instability (Tanic 
et al., 2009). However, such high levels of genomic instability in leukoplakia samples were a 
surprise mainly because they are defined as white patches or plaques of oral mucosa that 
cannot be rubbed off and cannot be diagnosed clinically or pathologically as other specific 
diseases and have been considered premalignant lesions only since recently (Neville & Day, 
2002; Hunter et al., 2005). It is impossible to state, with precision, the proportion of 
leukoplakias that undergo malignant transformation. For oral mucosa, in general, up to 20% 
of leukoplakias exhibit dysplasia. Dysplastic leukoplakias have a greater probability of 
developing into cancer, although leukoplakias without evidence of dysplastic changes may 
also progress to highly aggressive squamous cell carcinoma. Still, the majority of 
leukoplakias fail to undergo malignant transformation. The frequency of malignant 
alterations in oral leukoplakia varies from study to study and ranges from 8.9 to 17.5% 
(summarized in Neville & Day, 2002). These facts and our finding were the reasons to 
include samples of Head and Neck Squamous Cell Carcinoma patients, identify and 
quantify genomic instability in these samples and compare obtained results with those of 
leukoplakia samples.  
Obtained frequency of DNA alterations in HNSCC samples was significantly lower than 
that of leukoplakia samples, as shown in Table 3. When comparing mean frequencies of 
DNA alterations the result is even more convincing. Namely, mean frequency of total DNA 
changes was 0.42 for leukoplakia samples vs. 0.28 for HNSCC samples. Interestingly, 
contribution of quantitative changes to the total instability in HNSCC samples is 
significantly higher (0.21) than the contribution of qualitative changes (0.16) which is quite 
opposite in leukoplakia samples. In other words, the level of genomic instability decreased 
during HNSCC promotion from premalignant lesions but more serious alterations, 
quantitative changes as manifestations of chromosomal instability, were selected. These 
results fit nicely into Darwinian evolutionary theory of neoplastic transformation. High 
instability is present at the very beginning of HNSCC genesis, providing genetic variability 
in the population of premalignant cells, which is absolutely necessary for the evolution by 
natural selection. During tumor progression the level of instability decreases due to 
selection of genotypes that are better adapted to the micro-environment in which natural 
selection took place. However, the question remains: why the majority of leukoplakias with 
such a huge instability fail to undergo malignant transformation? The answer may be in 
exceeding the error threshold for cell replication and viability (Eigen, 1993) with so many 
mutations. In other words, it seems that leukoplakias with a high degree of genomic 
instability have less chance to develop into HNSCC, whereas leukoplakias with a lower 
(moderate) degree of genomic instability have a better chance of transforming, probably 
because they carry a certain number of mutations that have favorable effects on cell growth 
(Tanic et al., 2009). 
Following the same reasoning as in the case of NSCLC we attempted to identify some of 
detected DNA changes in leukoplakias, with the aim of identifying tumor-specific 
alterations (Peinado et al., 1992) that could lead to the development of potential diagnostic 
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markers involved in the genesis of HNSCC. To that end, nine variant bands present in 
leukoplakias but not in normal tissue, were selected. Unexpectedly, two different amplicons, 
originating from distinct leukoplakias, were identified as altered part of the TIMP-3 gene 
(tissue inhibitors of metalloproteinases 3), two were identified as mutated DNMT 3A gene 
(DNA (cytosine-5)-methyltransferase 3 alpha) and two represented copies of the Ty1-copia-
like retrotransposon.  
Further investigations of the detected genes in both, leukoplakia and NSCLC samples, on 
larger sample size, with special emphases on tumor promoting genes, are underway. We 
expect more detailed profile of their involvement in NSCLC and HNSCC after extensive 
analyses of their mutational status and detailed analyses of their expression profile at RNA 
and protein level in a larger sample. We expect that some of them might prove to be a good 
prognostic biomarkers for NSCLC or HNSCC patients. 
Finally, we analyzed malignant gliomas, tumors that originate from glia, the most common 
and deadly brain tumors. All patients had histologically confirmed diagnosis of anaplastic 
astrocytoma (AA) or glioblastoma multiforme (GBM) according to the new World Health 
Organisation (WHO) classification. Anaplastic astrocytomas (WHO grade III) and 
glioblastomas (WHO grade IV) are two major groups of malignant gliomas. Glioblastomas 
are further classified as primary and secondary. Distinction between them is based on 
different genetic pathways leading to their development (Ohgaki & Kleihues, 2007; Van 
Meir et al., 2010). Primary glioblastoma develop rapidly de novo, without clinical or 
histological evidence of a less malignant precursor lesion. Secondary glioblastoma develop 
slowly progressing from low-grade diffuse astrocytoma (WHO grade II) or anaplastic 
astrocytoma (WHO grade III). 
Examination of the extent of genomic instability revealed that samples of patients with 
anaplastic astrocytoma had similar level of total, microsatellite and chromosomal genomic 
instability as patients with glioblastoma multiforme, with very high values in both 
histological subtypes (Table 4). It was unexpected and, at first sight, looked like these 
results contradicted the expectation and results obtained from NSCLC and HNSCC 
samples. However, all analyzed grade IV glioblastomas were classified as primary 
glioblastomas (because glioblastoma diagnosis was made at the first biopsy, without 
clinical or histopathologic evidence of a less malignant precursor lesion), which are 
considered to be de novo tumors and not the progressive form of grade III astrocytomas. 
Therefore, obtained results are still consistent with the evolutionary theory of neoplastic 
transformation and the decrease of the level of genomic instability could be expected in 
secondary glioblastomas. In other words, extensive genomic instability might be used as 
diagnostic character where pathology cannot provide unambiguous distinction between 
primary and secondary GBM. Similar results were obtained by Nishizaki et al. (2002) who 
demonstrated that there was no significant difference in FISH heterogeneity between 
malignant gliomas of WHO grades III and IV. We expect that further research involving 
secondary glioblastomas will confirm our hypothesis and will provide additional 
confirmation for the evolutionary theory of tumor progression. Moreover, we hope that 
cloning and sequencing of amplified DNA bands showing genetic alterations specific for 
glioma genome, will allow the detection of new genes implicated in glioma pathogenesis 
and progression. 
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instability 
Mean frequency 
Anaplastic Astrocytoma vs. Glioblastoma Multiforme 
microsatellite 0.15 vs. 0.16 
chromosomal 0.19 vs. 0.16 
TOTAL 0.34 vs. 0.33 
Table 4. Mean frequency of DNA alterations in malignant glioma samples. 
Finally, it is worth mentioning that measurements of genomic instability could be 
performed by another DNA fingerprinting technique, RAPD (Random Amplified 
Polymorphic DNA). Wang et al. (2002) measured genomic instability in various cancer types 
using RAPD and the instability they detected was in average higher than 40% for lung 
cancer tissues. In another study (Ong et al., 1998), DNAs from 20 lung cancer (18 non-small 
cell lung cancers and two small cell lung cancers) and their corresponding normal tissues 
were amplified individually by RAPD with seven different 10-base arbitrary primers. PCR 
products from RAPD were electrophoretically separated in agarose gels and banding 
profiles were visualized by ethidium bromide staining. The ability to detect genomic 
instability in 20 cancer tissues by each single primer ranged from 15 to 75%. DNA changes 
were detected by at least one primer in 19 (95%) cancer tissues. They concluded that these 
results seem to indicate that genomic rearrangement is associated with lung carcinogenesis 
and that RAPD analysis is useful for the detection of genomic instability in lung cancer 
tissues. 
Misra A. et al. (2007) used RAPD to attempt to quantify the number of clonal mutations in 
primary human gliomas of astrocytic cell origin . They targeted genomic loci of a different 
nature and estimated that the number of overall alterations in tumor genome seemed to be 
greater than expected. They also observed a higher number of genetic changes in tumors of 
lower grade and suggested that it could be a consequence of an increased mutation rate in 
early tumorigenesis due to acquisition of a mutator phenotype. The increased extent of 
alterations occurring in tumors of a lower grade is consistent with our study. The results of 
Misra et al. showed the acquisition of a mutator phenotype early in tumorigenesis and 
support the mutator hypothesis proposed by Loeb (1991, 2001).  
4. Conclusions 
AP-PCR DNA fingerprinting is an efficient tool to quickly and easily screen a very large 
number of loci for possible DNA alterations in cancer cells. It has several advantages: first, 
minor amounts of template DNA are sufficient for analysis; second, it allows for the 
screening of anonymous regions of a genome without any prior knowledge of its structure; 
third, two types of DNA alterations could be detected in single reaction, chromosomal 
rearrangements and random mutations dispersed over the genome; and forth, possibility of 
reamplification, cloning and sequencing of variant bands enables the rapid identification of 
the genes probably linked to tumor progression. Here, we demonstrated the use of AP-PCR 
DNA fingerprinting in detection and quantification of genomic instability (microsatellite, 
chromosomal and total) in three types of tumors as well as in search for molecular 
biomarkers for cancer promotion and progression. Therefore, we conclude that AP-PCR 
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DNA fingerprinting is important and practically feasible technique for elucidating the 
genetic background of various tumors. Accordingly, we believe that this technique is rather 
neglected in contemporary research and should  make a comeback because it still has a 
particularly promising future in experimental oncology. 
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